Publication:
Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes.

Simple item page
dc.contributor.authorReverté, Laia
dc.contributor.authorYeregui, Elena
dc.contributor.authorOlona, Montserrat
dc.contributor.authorGutiérrez-Valencia, Alicia
dc.contributor.authorBuzón, Maria José
dc.contributor.authorMartí, Anna
dc.contributor.authorGómez-Bertomeu, Frederic
dc.contributor.authorAuguet, Teresa
dc.contributor.authorLópez-Cortés, Luis F
dc.contributor.authorBurgos, Joaquin
dc.contributor.authorBenavent-Bofill, Clara
dc.contributor.authorBoqué, Carme
dc.contributor.authorGarcía-Pardo, Graciano
dc.contributor.authorRuiz-Mateos, Ezequiel
dc.contributor.authorMestre, Maria Teresa
dc.contributor.authorVidal, Francesc
dc.contributor.authorViladés, Consuelo
dc.contributor.authorPeraire, Joaquim
dc.contributor.authorRull, Anna
dc.contributor.authorCOVIDOMICS Study Group
dc.date.accessioned2023-05-03T14:36:45Z
dc.date.available2023-05-03T14:36:45Z
dc.date.issued2022
dc.identifier.doi10.1002/ctm2.704
dc.identifier.essn2001-1326
dc.identifier.pmcPMC8787095
dc.identifier.pmid35075803
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787095/pdf
dc.identifier.unpaywallURLhttps://doi.org/10.1002/ctm2.704
dc.identifier.urihttp://hdl.handle.net/10668/21851
dc.issue.number1
dc.journal.titleClinical and translational medicine
dc.journal.titleabbreviationClin Transl Med
dc.language.isoen
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.page.numbere704
dc.pubmedtypeLetter
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshAlpha-Globulins
dc.subject.meshBiomarkers
dc.subject.meshCOVID-19
dc.subject.meshCholesterol Esters
dc.subject.meshGlutamic Acid
dc.subject.meshHumans
dc.subject.meshSeverity of Illness Index
dc.subject.meshTreatment Outcome
dc.titleFetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number12
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PMC8787095.pdf
Size:
1.45 MB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Virgen del Rocío
Instituto de Investigación Biomédica de Sevilla (IBIS)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía